DermWire | Newest Articles http://practicaldermatology.com/dermwire/ Newest Articles en-us Thu, 4 Jun 2020 20:44:27 GMT Thu, 4 Jun 2020 20:44:27 GMT DermWire PALLAS Ti:Sapphire Solid State Laser Shows Similar Efficacy and Safety to 308nm Excimer Laser for Localized Vitiligo http://practicaldermatology.com/dermwire/view.asp?url=pallas-tisapphire-solid-state-laser-shows-similar-efficacy-and-safety-to-308nm-excimer-laser-for-localized-vitiligo A novel 311nm Titanium:Sapphire UV laser demonstrates comparable efficacy and safety when compared to 308nm excimer laser in the treatment of localized vitiligo, according to a study recently published in Lasers in Surgery and Medicine. Manufactured by LASEROPTEK Co. Ltd., PALLAS is a gain switched, Ti:Sapphire solid state 311nm UV-B laser and is CE Marked as well as US Food and Drug Administration cleared for UV phototherapy of psoriasis, vitiligo, atopic dermatitis and leukoderma. The t… Thu, 28 Mar 2019 04:00:00 GMT Meet JOULE X and More New Offerings from Sciton at ASLMS http://practicaldermatology.com/dermwire/view.asp?url=meet-joule-x-and-more-new-offerings-from-sciton-at-aslms Sciton Inc. unveiled JOULE X and other new offerings at the annual American Society for Laser Medicine and Surgery Meeting in Denver, Colorado. An upgrade to the JOULE platform, JOULE X is the company’s latest multi-device platform. It works with HALO, diVa, Resurfacing Perfected, Allura and BBL (BroadBand Light) and features three distinct delivery modes: arm, fiber, and broadband light. "We are bringing even more value with novel technology offerings including SCITON iQ, a rev… Thu, 28 Mar 2019 04:00:00 GMT BTL to Launch Small Emsculpt Applicator for Arms, Thighs, Calves http://practicaldermatology.com/dermwire/view.asp?url=btl-to-launch-small-emsculpt-applicator-for-arms-thighs-calves BTL is rolling out a small Emsculpt applicator to treat arms, thighs and calves at the annual meeting of the American Society for Laser Medicine and Surgery in Denver. Until now, there were only protocols for the abdominals and buttocks. In addition to launching the small applicator, BTL will also highlight new clinical findings demonstrating long-term Emsculpt results with six-month and one-year data at the meeting. Thu, 28 Mar 2019 04:00:00 GMT Now Available: neuLASH Professional and neuBROW Professional http://practicaldermatology.com/dermwire/view.asp?url=now-available-neulash-professional-and-neubrow-professional New from Skin Research Professional and Olive and Delmar, neuLASH PROFESSIONAL™ and neuBROW PROFESSIONAL™ are available in all new, next-generation, professional-strength formulations. neuLASH PROFESSIONAL™ is a peptide serum promoting longer-looking lashes and neuBROW PROFESSIONAL™ is an eyebrow serum to promote fuller-looking brows. Available exclusively through Olive and Delmar, a physician-owned skin care solutions company, the neuLASH PROFESSIONAL and neuBROW PR… Wed, 27 Mar 2019 04:00:00 GMT Allergan Acquires Envy Medical, Inc. http://practicaldermatology.com/dermwire/view.asp?url=allergan-acquires-envy-medical-inc Allergan now owns Envy Medical, Inc. The acquisition adds Envy's Dermalinfusion, a non-surgical, non-invasive skin resurfacing system for the face and body, to Allergan's portfolio. Offered in physician's offices, medical spas and luxury spas, Dermalinfusion exfoliates, extracts and infuses the skin with professional strength serums, using medical grade diamond treatment tips. Each serum is specifically formulated to help treat a variety of skin concerns across all skin types. In… Tue, 26 Mar 2019 04:00:00 GMT Nextech Partners with RxPhoto for Integrated Image Management http://practicaldermatology.com/dermwire/view.asp?url=nextech-partners-with-rxphoto-for-integrated-image-management Nextech Systems has launched a new partnership with RxPhoto, a collaborative medical imagery solution. This partnership integrates RxPhoto’s patient photography app within Nextech’s existing technology workflows for plastic surgery, dermatology and medical spa clients. When Nextech software is partnered with the HIPAA compliant, image-capturing app, both help to create a replicable patient experience that simultaneously improves patient flow and retention. RxPhoto’s on-scre… Mon, 25 Mar 2019 04:00:00 GMT Biofrontera Acquires Cutanea Life Sciences http://practicaldermatology.com/dermwire/view.asp?url=biofrontera-acquires-cutanea-life-sciences Biofrontera Inc., USA entered into an agreement to acquire all shares in Cutanea Life Sciences, Inc., USA through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller. Maruho holds approximately 20 percent of Biofrontera AG. Cutanea is a US-based pharmaceutical company that markets Aktipak, a prescription gel for the treatment of acne. In November 2018, Cutanea also launched Xepi, a prescription cream for the treatment of impetigo. XepiTM is the only… Mon, 25 Mar 2019 04:00:00 GMT Cutera Hosts Beauty Talk with Sadick and Sadick http://practicaldermatology.com/dermwire/view.asp?url=cuter-hosts-beauty-talk-with-sadick-and-sadick Dermatologist Neil Sadick, MD and his daughter Sydney Sadick, an in-the-know fashion journalist, talked about everything from state-of-the-art skin brightening treatments to the newest injectables and how to get svelte without sweating or surgery at a recent Beauty Talk hosted by Cutera at Dr. Sadick's Mahattan practice. It takes a lot of work and a little help from a great dermatologist to look good. According to Sydney Sadick, “Millennials are more obsessed now with their appearan… Thu, 21 Mar 2019 04:00:00 GMT Biofrontera Reports Positive Phase 3 Results with Ameluz for PDT of AKs on Extremities and Trunk/Neck http://practicaldermatology.com/dermwire/view.asp?url=biofrontera-reports-positive-phase-3-results-with-ameluz-for-pdt-of-aks-on-extremities-and-trunkneck Results for the primary endpoint of Biofrontera AG's Phase 3 clinical trial evaluating the safety and efficacy of conventional photodynamic therapy (PDT) with Ameluz and the BF-RhodoLED lamp for the treatment of actinic keratoses (AK) on the extremities as well as the trunk and neck are postive. The study met its primary regulatory endpoint, demonstrating that Ameluz was superior to placebo based on its mean total lesion clearance rate of 86 percent compared to 33 percent for placebo. These … Thu, 21 Mar 2019 04:00:00 GMT Lead Pharma Begins Phase I Trials with SAR441169 Candidate Treatment for Psoriasis http://practicaldermatology.com/dermwire/view.asp?url=lead-pharma-to-begin-phase-i-trials-with-sar441169-candidate-treatment-for-psoriasis Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, achieved a fourth milestone under its license & collaboration agreement with Sanofi, triggering an undisclosed milestone payment. The milestone payment is linked to Sanofi’s dosing of the first human volunteers in a Phase I clinical trial of SAR441169, a novel inverse agonist of the nuclear hormone receptor RORγt. “We are excited to have r… Thu, 21 Mar 2019 04:00:00 GMT CoolSculpting and Sonja Morgan Partner to Talk Bikini Denial http://practicaldermatology.com/dermwire/view.asp?url=coolsculpting-and-sonja-morgan-partner-to-talk-bikini-denial Star of Bravo's "The Real Housewives of New York City" Sonja Morgan is opening up about her ‘Bikini Denial’ as part of her partnership with CoolSculpting. Bikini Denial is the feeling that many woman get when realizing that swimsuit season has snuck up on her and she is not prepared to bare it all at the beach or pool until she frees herself of stubborn fat. The belly is most common area women feel self-conscious about, according to a recent survey. As the face of… Wed, 20 Mar 2019 04:00:00 GMT Are Skin Diseases More Common Than Previously Held? http://practicaldermatology.com/dermwire/view.asp?url=are-skin-diseases-more-common-than-previously-held Skin diseases may be more common than previously believed, according to a new study in the Journal of the European Academy of Dermatology and Venereology that estimates the prevalence of skin diseases outside of the typical medical setting. Skin diseases are ranked as the fourth most common cause of human illness, but many affected people do not consult a physician. To include people who never or rarely seek medical aid, researchers collected data at the Munich Oktoberfest in Germany where sc… Wed, 20 Mar 2019 04:00:00 GMT More Positive Results Seen with Endo’s Injectable Cellulite Treatment http://practicaldermatology.com/dermwire/view.asp?url=more-positive-results-for-endos-injectable-cellulite-treatment Endo International plc’s injectable cellulite treatment collagenase clostridium histolyticum ("CCH") showed a clinically meaningful and statistically significant improvement compared to placebo for all primary and secondary endpoints in a Phase 2 study. The findings, which appear in Dermatologic Surgery, are consistent with the recently released Phase 3 studies. CCH is an investigational injectable treatment designed specifically to reduce the appearance of cellulite by di… Tue, 19 Mar 2019 04:00:00 GMT Jean Bolognia, MD Honored with AAD Gold Medal http://practicaldermatology.com/dermwire/view.asp?url=jean-bolognia-md-honored-with-aad-gold-medal During the 2019 Annual Meeting of the American Academy of Dermatology (AAD) in Washington, D.C., the AAD awarded Jean Bolognia, MD, Professor of Dermatology at the Yale University School of Medicine, with its Gold Medal. The AAD's highest honor, the Gold Medal Award is given to individuals who have demonstrated outstanding and exceptional service to dermatology in the science, teaching, and practice of cutaneous medicine and surgery. Dr. Bolognia has actively served on the Board of Directors… Tue, 19 Mar 2019 04:00:00 GMT AAD Announces 2019 Election Results http://practicaldermatology.com/dermwire/view.asp?url=aad-announces-2019-election-results The votes have been counted in the 2019 AAD Election, and the following candidates will take office at the conclusion of the 2020 Annual Meeting in Denver, Colorado on March 24, 2020. The President-Elect is Kenneth J. Tomecki, MD, FAAD and the Vice President-Elect is Neal Bhatia, MD, FAAD, who is also Practical Dermatology's Chief Medical Editor. The new members of the Board of Directors are Murad Alam, MD, MSCI, MBA, FAAD; Cheryl M. Burgess, MD, FAAD; Naomi Lawrence, MD, FAAD; and Amy Mc… Tue, 19 Mar 2019 04:00:00 GMT Galderma Collaborates with Nespresso to Offer Patient Loyalty Incentive Program http://practicaldermatology.com/dermwire/view.asp?url=galderma-collaborates-with-nespresso-to-offer-patient-loyalty-incentive-program Galderma Laboratories, L.P., recently teamed up with Nespresso to offer a new rewards program for patients who seek Restylane treatments from aesthetic professionals. With a qualifying purchase of Restylane dermal fillers, aesthetic professionals will receive a set of vouchers for complimentary Nespresso VertuoPlus machines to offer their patients receiving Restylane treatments. The program is being offered nationally while supplies last. "Our collaboration with Nespresso provides a uniq… Mon, 18 Mar 2019 04:00:00 GMT Dermira’s Investigational AD Drug Performs Well in Phase 2b Trial, Shares Skyrocket http://practicaldermatology.com/dermwire/view.asp?url=ready-for-phase-3-dermiras-investigational-ad-drug-performs-well-in-phase-2b-trial All three doses of Dermira, Inc.’s lebrikizumab showed greater improvements in the Eczema Area and Severity Index in a new Phase 2b dose-ranging study of adults with moderate-to-severe atopic dermatitis, and shares of Dermira, Inc. skyrocketed in premarket trading after the company announced these results. Lebrikizumab is a novel, humanized monoclonal antibody designed to bind IL-13 with high affinity, specifically preventing the formation of the IL-13Rα1/IL-4Rα heterodimer … Mon, 18 Mar 2019 04:00:00 GMT Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc. http://practicaldermatology.com/dermwire/view.asp?url=constellation-alpha-capital-corp-signs-letter-of-intent-to-acquire-dermtech-inc Constellation Alpha Capital Corp., a special purpose acquisition company, has executed a non-binding Letter of Intent to merge with DermTech, Inc., a molecular genomics company with an initial focus on skin cancer. DermTech markets and develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and help customize drug treatment. DermTech analyzes skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech's mission is… Fri, 15 Mar 2019 04:00:00 GMT Pilot Study: Regular Moisturization May Cut Dementia Risk http://practicaldermatology.com/dermwire/view.asp?url=pilot-study-regular-moisturization-may-cut-dementia-risk Inflamed skin in older adults may contribute to a wide range of age-related conditions including heart disease and Alzheimer’s disease, but regular moisturization may cool the inflammation and lower disease risk in the process, according to a pilot study. In the study, 33 adults aged 58 and 95 applied a lipid-balanced cream all over their bodies twice a day for 30 days. After a month, the researchers measured blood levels of three cytokines -- interleukin-1 beta, interleukin-6, and tumo… Fri, 15 Mar 2019 04:00:00 GMT History of Dermatology Society Names Samuel J. Zakon Awardee http://practicaldermatology.com/dermwire/view.asp?url=history-of-dermatology-society-names-samuel-j-zakon-awardee Frederick C. Gaede, BA, MAS, has received the Samuel J. Zakon Award in the History of Dermatology for his article entitled “Henry Granger Piffard, MD and His Photogenic Pistol Cartridges.” The Award was announced at the forty-sixth annual meeting of the History of Dermatology Society in Washington DC last month. Also recognized at the meeting was Irwin M. Braverman, MD from New Haven, CT. Dr. Braverman presented the lecture, “Wax, Limestone, and Paper: The Foundation of Derm… Wed, 13 Mar 2019 04:00:00 GMT DefenAge’s D2-Minute Reveal Masque Named NewBeauty's 2019 Best Brightening Mask http://practicaldermatology.com/dermwire/view.asp?url=defenages-d2-minute-reveal-masque-named-newbeautys-2019-best-brightening-mask DefenAge’s D2-Minute Reveal Masque is the NewBeauty 2019 Award Winner for “Best Brightening Mask.” Each year, the NewBeauty Awards showcase the most innovative products that have the distinct ability to solve beauty’s biggest problems. Thousands of products and treatments are vetted by industry experts, NewBeauty editors and readers, and winners are announced each Spring. The DefenAge 2-Minute Reveal Masque resurfaces, refines and reveals brighter, younger-looking … Wed, 13 Mar 2019 04:00:00 GMT Study: Port Wine Stain Laser Treatment Is Safe and Effective in Infants Without Anesthesia http://practicaldermatology.com/dermwire/view.asp?url=study-port-wine-stain-laser-treatment-is-safe-and-effective-in-infants-without-anesthesia Recent concerns about the repetitive use of general anesthesia in children younger than 3 have placed greater importance on the controversy surrounding the timing of port-wine stain laser treatment, but a new study shows that such treatment does not necessarily require anesthesia. In a retrospective analysis of 197 infants with port-wine stains who began laser treatment during infancy, 34 percent of the patients achieved 100 percent clearance and 37.6 percent showed 76 percent to 99 percent i… Wed, 13 Mar 2019 04:00:00 GMT FDA Approves Dupixent for Moderate to Severe AD in Adolescents http://practicaldermatology.com/dermwire/view.asp?url=us-fda-approves-dupixent-for-moderate-to-severe-atopic-dermatitis-in-adolescents The FDA has approved expanded use of Regeneron Pharmaceuticals Inc and Sanofi SA's eczema drug Dupixent to include patients aged 12 through 17 whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. Dupixent can be used with or without topical corticosteroids. "For the first time, adolescents with uncontrolled moderate-to-severe atopic dermatitis have an approved biologic treatment option to help control persistent,… Mon, 11 Mar 2019 04:00:00 GMT BTL HIFEM Devices Honored by Harper's Bazaar, NewBeauty http://practicaldermatology.com/dermwire/view.asp?url=btl-hifem-devices-honored-by-harpers-bazaar-newbeauty BTL has received two new accolades from NewBeauty and Harper's Bazaar magazines. Both EMSCULPT and BTL EMSELLA received a NewBeauty Innovation Award, as featured in the Spring issue, on stands today. EMSCULPT was also named a 2019 Harper's Bazaar Anti-Aging Award Winner. Only eleven "Innovation" honors were awarded by NewBeautythis year, with BTL earning two of the coveted spots on the list. Hailed as a treatment that captured the attention of both beauty enthusiasts and aes… Mon, 11 Mar 2019 04:00:00 GMT 2019 NewBeauty Awards: Alastin's TransFORM Body Treatment Acknowledged for Innovation http://practicaldermatology.com/dermwire/view.asp?url=2019-newbeauty-awards-alastins-transform-body-treatment-acknowledged-for-innovation ALASTIN Skincare, Inc’s TransFORM Body Treatment has been awarded a 2019 NewBeauty Award in the innovations category. NewBeauty acknowledges the best products, treatments and trends in cosmetics and aesthetics with their innovation category described as, "the future is now: these no-frills releases do what was previously only a dream." TransFORM Body Treatment with TriHex Technology®is a topical body treatment that works in tandem with non-surgical body fat reduction and e… Mon, 11 Mar 2019 04:00:00 GMT